Experimentally-guided in silico design of engineered heart tissues to improve cardiac electrical function after myocardial infarction.

Cardiac electrophysiology Human induced pluripotent stem cells In silico modeling and simulation Myocardial infarction Scaffold design Tissue engineering Ventricular assist device

Journal

Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 14 08 2023
revised: 23 12 2023
accepted: 26 01 2024
pubmed: 10 2 2024
medline: 10 2 2024
entrez: 9 2 2024
Statut: ppublish

Résumé

Engineered heart tissues (EHTs) built from human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) showed promising results for cardiac function restoration following myocardial infarction. Nevertheless, human iPSC-CMs have longer action potential and lower cell-to-cell coupling than adult-like CMs. These immature electrophysiological properties favor arrhythmias due to the generation of electrophysiological gradients when hiPSC-CMs are injected in the cardiac tissue. Culturing hiPSC-CMs on three-dimensional (3D) scaffolds can promote their maturation and influence their alignment. However, it is still uncertain how on-scaffold culturing influences the overall electrophysiology of the in vitro and implanted EHTs, as it requires expensive and time consuming experimentation. Here, we computationally investigated the impact of the scaffold design on the EHT electrical depolarization and repolarization before and after engraftment on infarcted tissue. We first acquired and processed electrical recordings from in vitro EHTs, which we used to calibrate the modeling and simulation of in silico EHTs to replicate experimental outcomes. Next, we built in silico EHT models for a range of scaffold pore sizes, shapes (square, rectangular, auxetic, hexagonal) and thicknesses. In this setup, we found that scaffolds made of small (0.2 mm

Identifiants

pubmed: 38335818
pii: S0010-4825(24)00128-8
doi: 10.1016/j.compbiomed.2024.108044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108044

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Ricardo M Rosales (RM)

Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Aragón, Spain; CIBER-BBN, ISCIII, Madrid, Spain; Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Aragón, Spain. Electronic address: rrosales@unizar.es.

Konstantinos A Mountris (KA)

Department of Mechanical Engineering, University College London, London, United Kingdom. Electronic address: k.mountris@ucl.ac.uk.

Aida Oliván-Viguera (A)

Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Aragón, Spain; CIBER-BBN, ISCIII, Madrid, Spain; Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Aragón, Spain. Electronic address: aolivanv@unizar.es.

María Pérez-Zabalza (M)

Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Aragón, Spain; CIBER-BBN, ISCIII, Madrid, Spain; Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Aragón, Spain; Defense University Centre (CUD), Zaragoza, Spain. Electronic address: mariapzabalza@unizar.es.

Gerardo Cedillo-Servin (G)

Regenerative Medicine Center, Utrecht, The Netherlands; Department of Orthopedics, University Medical Center, Utrecht, The Netherlands. Electronic address: g.cedilloservin@umcutrecht.nl.

Olalla Iglesias-García (O)

Regenerative Medicine Program, CIMA Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain. Electronic address: oiglesias@unav.es.

Andrei Hrynevich (A)

Regenerative Medicine Center, Utrecht, The Netherlands; Department of Orthopedics, University Medical Center, Utrecht, The Netherlands. Electronic address: a.hrynevich@umcutrecht.nl.

Miguel Castilho (M)

Department of Orthopedics, University Medical Center, Utrecht, The Netherlands; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. Electronic address: m.dias.castilho@tue.nl.

Jos Malda (J)

Regenerative Medicine Center, Utrecht, The Netherlands; Department of Orthopedics, University Medical Center, Utrecht, The Netherlands; Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. Electronic address: j.malda@umcutrecht.nl.

Felipe Prósper (F)

Regenerative Medicine Program, CIMA Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain; Hematology and Cell Therapy, Clínica Universidad de Navarra, Pamplona, Spain; CIBER de Cáncer (CIBERONC, team CB16/12/00489), Pamplona, Spain. Electronic address: fprosper@unav.es.

Manuel Doblaré (M)

Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Aragón, Spain; CIBER-BBN, ISCIII, Madrid, Spain; Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Aragón, Spain. Electronic address: mdoblare@unizar.es.

Manuel M Mazo (MM)

Regenerative Medicine Program, CIMA Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain; Hematology and Cell Therapy, Clínica Universidad de Navarra, Pamplona, Spain. Electronic address: mmazoveg@unav.es.

Esther Pueyo (E)

Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Aragón, Spain; CIBER-BBN, ISCIII, Madrid, Spain; Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Aragón, Spain. Electronic address: epueyo@unizar.es.

Classifications MeSH